TORONTO--(BUSINESS WIRE)--Alpha Cancer Technologies Inc. (ACT) a biopharmaceutical company focused on developing and commercializing targeted immuno-oncology and immunology therapies based on its ...
With the expertise of its clinical teams, advanced technical capabilities, and active clinical research programs, Sainte-Catherine ranks among the leading cancer centers in France. The institution has ...
TORONTO--(BUSINESS WIRE)--Alpha Cancer Technologies Inc. (ACT), a biopharmaceutical company focused on developing and commercializing targeted immuno-oncology and immunomodulation therapies based on ...
May 19, 2011 (Philadelphia, Pennsylvania) — A low serum albumin or high alpha-fetoprotein (AFP) level independently predicted mortality when hepatocellular carcinoma (HCC) recurred after liver ...
Abbott announced that the FDA has approved Architect AFP, a test to help detect serious birth defects and the progression of testicular cancer. Alpha-fetoprotein (AFP) is a biomarker that can identify ...
Researchers have found that hormones produced during pregnancy induce a protein that directly inhibits the growth of breast cancer. This protein, alpha-fetoprotein, may serve as a viable, ...
Former US president Joe Biden's prostate cancer is likely too advanced to be cured but treatment could control the spread of the disease for years, experts told AFP. The revelation late Sunday that ...
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the initiation of the TheraPb Phase 2 expansion trial (NCT05720130) ...
A red ribbon used in cancer awareness campaign. The global burden of cancer continues to grow in spite of scientific advances. [Photo: AFP] Cancer will kill nearly 10 million people this year, experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback